Guided Therapeutics Inc (QB) (GTHP) News

GTHP has yet to publish whether or not SMI paid them 100K by March 31st 2024?
GTHP can’t alone submit to NMPA without SMI. If & when SMI will submit to NMPA (& that’s a big if) they are supposed to trigger a PO. Without that PO’s money coming in stock has no where else to go but downward spiral.

Because they finished the Chinese clinical trial and have the endorsement of Chinese gynecologists.

submission to the Chinese FDA can now happen whether SMI does it or not.

On why basis you say this? ☝️

Retracting your assertion of non-disclosure is like saying you're sorry after damaging someone's property. That doesn't repair the damage. The company can sue you for libel.

You're a lawyer. You know that.

GET: Item 13 which you posted:

Is 100% absent any disclosure that GTHP has to share fees it receives from SMI,(with Shenghou, LLC) which implies GTHP is retaining all these fees, this is a half truth and misrepresentation and thus in my viewpoint a non disclosure. I will leave it at that and I have never had a problem with you individually.

GET

Thanks for bringing this to my attention that this was mentioned in a 8k, which I never saw or knew about until you posted it, this can be said for other investors as well whom did not know about the GTHP - Shenghou fee split agreement. So I hereby immediately RETRACT MY COMMENT OF NON DISCLOSURE.

THE ITEM 13 YOU QUOTED:
13. SUBSEQUENT EVENTS

On February 17, 2024, the Company entered into a fourth amendment to the agreement with SMI. Under the terms of the amended agreement, SMI also agreed to pay the Company $531,100 on or prior to March 15, 2024. MAKES IT SOUND LIKE GTHP GETS ALL THESE FESS AND DOES NOT REFERENCE THAT THESE FEES ARE TO BE SHARED WITH SHENGHOU LLC , so perhaps this is misleading by not referencing again a fee spliting arrangement that most investors like yourself were unaware of.

What is MOST INTERESTING about your posting referencing the fee splitting agreement is: GTHP (disinterested Directors "effectively waived the conflict-of-interest provisions of the Company’s code of ethics." "On January 15, 2017, each of the disinterested directors on the Company’s Board of Directors, having considered the interests of Dr. Faupel and Mr. Blumberg and having approved the agreement, effectively waived the conflict-of-interest provisions of the Company’s code of ethics." THIS LOOKS LIKE A RED FLAG TO ME

I will again say that Shenghou LLC the original License Agreement Holder was a sham transaction, as Shenghou did not have the expertise to fulfill its obligation under the same, and perhaps it is a self directed dealing of GTHP assets - Splitting GTHP fees to insiders Faupel and Blumberg who are owners in Shenghou., LLC. and perhaps GTHP effectively waived its conflict of interests code to allow Faupel and Blumberg to receive compensation at the expense of the shareholders of GTHP, without having to disclose this as compensation to these two insiders at GTHP. I would call this turning a blind eye.

I saw that the judge threw out GIUL's conspiracy claims. Tell us what you know about that.

https://masslawyersweekly.com/files/2024/03/09-024-24.pdf

I just posted the link to the agreement -- and it was FREE.

That agreement has been in black-and-white for GTHP investors to see for quite some time. It is already DISCLOSED so you can stop posting your libelous statements, please and thank you.

I fail to see this agreement as a negative for GTHP investors. Shenghuo only gets money if SMI pays money. More important, without that agreement there would have been no SMI and there would be no Chinese clinical trials completed, because obviously Shenghuo wasn't going to accomplish anything in China.

The REAL value here is in the FDA approval. That's going to take awhile but I'm quite confident that this time the FDA will approve the device. FDA approval has nothing to do with your lawsuit and it has nothing to do with Shenghuo. If SMI pays any money, that will be icing on the cake (they already paid $330,000), but even if they don't pay any more money, they already accomplished a valuable feat: Chinese clinical trials were completed without costing Guided a lot of money, and the submission to the Chinese FDA can now happen whether SMI does it or not.

That has nothing to do with Guided Therapeutics and is therefore off topic.

Have your attorney send Mark Faupel a certified letter requesting that he disclose to you the terms of the agreement whereby GTHP has to share SMI revenue with the prior License Holder Shenghou, LLC. It should cost you less than 500 bucks. I will reimburse you for the same.

GIUL LLC law suit vs Mark Faupel, CEO of GTHP and Richard P. Blumberg, Director of GTHP, has been completed.

The Judge in the case is also acting as Jury and will fully decide the matter now pending and awaiting his ruling decision.

GIUL LLC in its submission of finding of facts claims Richard P. Blumberg told numerous lies when he testified under oath on the stand. Should the superior court trial judge agree on this issue that Blumberg committed perjury when he testified under oath - GIUL LLC will file a complaint with the SEC against Blumberg.

I don't believe you because one of these must be true:

* You are lying and therefore guilty of libel;

OR

* You are disclosing insider information and that is illegal.

Either way -- why should anyone trust you?

I believe the first bullet above describes the situation. The agreement to which you refer is disclosed in the financial statement as Exhibit 10.13, which makes YOU guilty of libel. Here is Exhibit 10.13 from the 10-K:

https://content.edgar-online.com/ExternalLink/EDGAR/0001121781-17-000006.html?hash=4440d5c8e862c59bf3763cf92d5c1b90ff360893e0a6c1f7044372876f5bc32a&dest=ex10two_htm#ex10two_htm

GTHP has a NON DISCLOSED AGREEMENT where GTHP has to share revenue from SMI with the previous License Holder Shenghou LLC, now know as K2, of which Richard Blumberg, now a board of Director Member of GTHP,, - Blumberg is also a manager of K2 and owns a portions of K2.

Again, I view this as self dealing assets of GTHP by insiders to themselves Blumberg and Mark Faupel also an owner of K2 (Faupel at one point was also a manager of K2). P

erhaps Faupel and Blumberg will be sued here by Shareholder of GTHP for self dealing assets - cash flow owed GTHP by SMI to an entity both Blumberg and Faupel are owners of at the expense to GTHP Shareholders?

Each of the 3 factual points you claim to have knowledge and understanding on is flat out WRONG!!! You really should check your facts before making such ridiculous comments as you are really just embarrassing yourself. Further, you must think you are the smartest guy in the room with your "Put your money where your mouth" challenge...give your head a shake man!!!!!

Do YOU have anything but FUD?

The clinical trials are taking longer than predicted. Do you ever read the filings, or do you just wait for me to explain them to you?

The clinical trials didn't finish in March 2024 as projected. That's the reason for the PPS decline. Accept that, or move on.

Do you have anything other than same old broken record FUD?
This company has a technological great product. However that product is in the wrong hands.
If you think this stock is undervalued or this stock has a potential to go up, then start buying. It’s time to put your money where your mouth is.

Do you know what FUD means?

Fear Uncertainty Doubt.

"This stock is at multi-year low" is a lie.
"In last 7+ years GTHP never saw a green day" is a lie.
"this stock will never see a day when it will close above 0.15$ & stay above 0.15$" is bullshit.

You are the FUD poster child. Congratulations.

Stock is at multi-year low & all of a sudden all bulls vanish. 😂
It’s time to finally admit that a great technological product like LuViva is in the wrong hands. Because of that long stockholders are suffering losses-over-losses-over-losses.
In last 7+ years GTHP never saw a green day.
As I said multiple times before this stock will never see a day when it will close above 0.15$ & stay above 0.15$
Open challenge to anyone to get this stock over 0.15$

Did you get a chance to read latest 10K?
Is there any good news in the latest 10K? Or is it still doom-&-gloom? SMI paying GTHP something that’s better than SMI paying GTHP nothing. Right? Is it time to slap a buy on ask? Or not yet?

I didn't read the 10-K word-for-word but I searched for some important strings. Here's the most interesting part:13. SUBSEQUENT EVENTS

On February 17, 2024, the Company entered into a fourth amendment to the agreement with SMI. Under the terms of the amended agreement, SMI also agreed to pay the Company $531,100 on or prior to March 15, 2024. On March 18, 2024, SMI, through SMI’s authorized distribution partner, initiated a wire payment of $330,000 in partial satisfaction of $531,100 owed to the Company. The payment was received by the Company on March 20, 2024. As the full payment was not received by March 15, 2024, the Company had the right to terminate the agreement with two weeks’ notice to SMI, however the Company did not exercise this option.



The amended agreement also provides for a timeline for the Company to deliver inventory during 2024, including LuViva devices and components, as well as approximately 1,640,000 RFID chips. In consideration, SMI agreed to pay a total of $4.4 million during 2024, including the payments due on March 15, 2024.



On March 27, 2024, the parties entered into a Standstill Agreement (the “Standstill Agreement”). The parties agreed that SMI will make a nonrefundable payment of $100,000 to the Company prior to March 31, 2024. In exchange, the Company will not initiate any legal proceedings, including but not limited to filing a lawsuit, obtaining a judgement, or enforcing any security interest, as related to the March shortfall in payments of $201,100, until April 30, 2024. Upon paying $100,000, SMI will have the option to extend the Standstill Agreement until June 15, 2024 by making a nonrefundable payment to the Company of $150,000. One additional payment of $150,000 may be made to extend the standstill rights until July 30, 2024, if mutually agreed upon. If SMI is unable to make the payments pursuant to the Standstill Agreement, the Company agreed to seek loans on behalf of SMI to cover the payments. SMI agreed to reimburse the Company for these loans along with all expenses associated with them within three months of the loans being issued as long as the loans are used solely for (1) parts for LuViva devices to be used by SMI for marketing and promotional activities, or (2) labor or consulting fees connected to providing parts, assemblies of devices or disposables to SMI. Additionally, SMI confirmed its commitment to make payments to GTI of at least $4.0 million during 2024 and as part of this commitment will make payments of $200,000 and $500,000 by the end of May 2024 and July 2024, respectively, to ensure that the program commercialization proceeds according to schedule.

To paraphrase: SMI paid some money! To my surprise, honestly. They didn't pay as much as promised, but they did pay $330,000 and they will pay a monthly penalty (about $100,000 for every 30 days) to kick the can down the road. It's called a "Standstill Agreement" and I've never heard of such a thing before.

SMI re-committed to paying $4 million in 2024 but they can't afford peanuts now so that continues to seem like an empty promise to me.

Otherwise, not much that's new. US clinical trials proceeding slowly. Debt decreased. Still over $400k in deferred revenue. SMI says they will submit the application to the NMPA in second quarter.

Blumberg just exercised warrants for 30 cents. See the newest Form 4.

Here's the reason why the judge in that civil case against Blumberg and Faupel ruled against a jury trial and directed the case to the court instead:

https://masslawyersweekly.com/files/2024/03/09-024-24.pdf

Trial ended, and they're waiting for the judge's decision. I've been following it here:

https://trellis.law/cases/1984CV02862?state=ma

Out of 103K stock traded today. Almost 95K was net sell. 10K at 0.1265$. Almost 50K at 0.13$ & rest was in between 0.14$ & 0.1265$
Sell sell & nothing but sell. Sell at any price you can get & sell at any bargain basement salvage price you can get. Just sell & get out of long position. Extremely bearish sentiment & no buying support at all.

What's wrong with that Form 4?

Do you understand it, or do you need an explanation? Are you filled with FUD about that Form 4 because you think that Imhoff is not really a Director or not really a person? Or have you given up on that line of BS? Do you remember when you claimed there was no evidence that any of the Directors were real people?

Do you know what "precipitously" means?

Do you remember how many times you claimed the PPS could not and would not get as high as 15 cents? You went off on THAT tirade for months.

Isn't it time to bring on your other alias to have a fake conversation with yourself, creating the illusion that SOMEONE agrees with you?

There’s no hope for this stock at all. When trade happens at 0.1590$, then the ask drops to 0.1580$. When trade happens at 0.1580$ then ask drops to 0.1579$. The bid price is not at all increasing & ask price keeps on dropping precipitously.
Also take a look at latest Form-4 filed.

History of GTHP for new investors - a primer

Of course, everyone does their own exhaustive DD before they buy a stock, but if any new investors want the Cliff notes:

GTHP got their 3rd FDA rejection in April 2015. Here's the PR:
https://www.otcmarkets.com/stock/GTHP/news/FDA-Completes-Review-of-Guided-Therapeutics-LuViva-Advanced-Cervical-Scan-PMA-Application?id=105061

The PR doesn't seem all that negative as FDA rejections go, but this rejection caught GTHP by surprise. Plan A was to get the PMA approval and get financing, so when the PMA was rejected they had no money and no plan B. The company fell into toxic death spiral financing with a couple of VERY shady lenders (One of which got into trouble with the SEC and caused them to dump in June 2023 but that's a different story). There was a 1:100 R/S in Feb 2016 and when the PPS tanked there was another R/S, this time 1:800, in 11/2016, but the PPS tanked even harder after that second R/S.

The company had no money and frankly not much hope of surviving, but somehow, Cartwright the CEO managed to get rid of the toxic lenders over the next few years. The company re-established communication with the FDA in 07/2017 and when they did the most recent R/S in March 2019, the resulting PPS of 15 cents has held.

They managed to get funding for a new clinical study, and it's coming to completion:
https://clinicaltrials.gov/study/NCT04915495

Notice I didn't mention SMI. I will believe the China Hype when GTHP gets a sizable check. If you read all the China PR's I think you'll agree that SMI has failed to fulfill their promises time and time again. The good news is that the China clinical study with 400 participants was apparently completed and was successful; that will bolster GTHP's amended PMA when they submit.

I have no doubt that the US clinical trial will be successful and that GTHP will submit the amended PMA. After that, it's hard to say how long the FDA will take to review the PMA, but it's an amended PMA, not a brand new submission. I also never assume any FDA submission is a slam dunk, but in my opinion, this is as close to a slam dunk as it gets.

I'm not sure why our resident basher is trying so hard to raise FUD. My only guess is that he held after that 2015 FDA rejection, which is something I've learned not to do -- yes I lost money in 2015 but I accept the risk of FDA plays, so I sold my entire position the day after that PR, took my loss, and moved on, watching and waiting. If our basher held, the R/S's in 2016 reduced his position to ashes, which I guess would make anyone bitter.

When that 2019 R/S held its resulting 15 cents, I started getting back in. It's not common for a pennystock developmental biotech hold its price after a R/S. It's SUPER uncommon. Our resident basher thinks the PPS should be at $5 but I'm surprised it didn't fall to a penny after that 3rd R/S.

So here we are, close to the milestone of completing that clinical trial and submitting the PMA. It would be nice if SMI mails a check because GTHP has to be out of cash by now, so I expect some bridge financing if SMI doesn't pony up. $500,000 from SMI in March would be a godsend, IMO, but again, I'll believe it when the check clears.

Also of note: it's important to know that the giul lawsuit against shenghuo does not name GTHP as a defendant. The lawsuit started in 2019 and originally it did name GTHP, but the company has since been removed from the lawsuit.

Cheers.

You win. You've worn me down with bullshit. I can no longer read your nonsense. Congratulations! You now have an audience of zero.

Are you really following this company? You kept on repeating “no news” “no news”. There are several news that this company put out starting with Chinese clinical starting, then US clinical started at 1 place, then Chinese clinical completed then US clinical started at 4 places etc. etc.
so you don’t know what you are talking about. There’s plenty of news out there the only news you are waiting for is US FDA approval & by that time this happens hopefully this stock price will be much higher.
If you are bullish why don’t you buy at ask?

See, you never answer a question or defend your opinion. You don't engage in a discussion or debate. You just keep banging a pot and shouting nonsense.

"Your challenge" is for someone to slap the ask and drive the PPS from 15 cents to $1 or $3 or $5 without news. That's absurd. An increase to $1 is a 600% increase. How often do you think that happens in pennystock biotech? Without news, the answer is "never." Even with news, a 600% increase is uncommon. Your "respectable $5" would be a 3000% increase. And if that doesn't happen, this stock is dead and will never rise above 15 cents, in your opinion. That's what you've stated over and over, even when it does rise above 15 cents, and you'll keep shouting that until, when, the PPS hits $5.00 ?

Oh joy.

If you are bullish on the stock then, why aren’t you buying at ask price?
My challenge is open to anyone who’s bullish on the stock. Can you get this stock to a respectable level of 1$ or 3$ or 5$ or higher? Anyone?

Yes, I read your posts, tedious though that endeavor may be. Nobody else is reading your posts because you're just mindlessly bashing with FUD nonsense, but I still read them.

Fine, if you want to play a semantics game -- if the "market" is bearish on GTHP, why isn't the "market" shorting this stock?

And I repeat my previous question: why aren't YOU shorting this stock if you think the "market" is bearish on GTHP? You must not agree with the "market."

the "market," LOL

Do you read my posts? I always said “market” is bearish & “market” neither have any interest in buying nor “market” is providing any buying support. However just now CDEL joined the party. They have 5000 stock bid at 0.15$. Let’s see if that bid is going to be taken.

if you're so bearish, why aren't you shorting?

You said it, since there’s a delay in getting payment from SMI that’s the reason yesterday’s sell off & bearish sentiment. Neither buyers nor any buying interest.

"Getting any payment from SMI" will be "a big deal & big news" if/when it happens, but there was no payment. Read it again. This PR was basically a repeat of the previous PR -- the only thing new is the delay in SMI paying GTHP.

But I apologize for interrupting your message of FUD. Please, resume your wailing and gnashing of teeth. If you can drive weak hands and amateurs down into my buy orders, that would be fine.

Carry on, Elmer FUD.

If there would not have been any bearish sentiment then there would not have been huge sells today. Market agrees with me & that’s why there are huge sells. Getting any payment from SMI is a big deal & big news. In spite of today’s good news the stock sold off. That clearly proves huge bearish sentiment.

LOL no the bearish sentiment is just you and the guy suing Shenghuo, and even HE shut up.

There's not much buying interest now, which is what you'd expect from a pennystock biotech this far under the radar. The China news isn't fooling anyone, although we all might be surprised some day when SMI sends a check.

There's going to be buying interest, IMO, when they finish the clinical trial, submit the amended PMA, and get FDA approval. You just don't see many penny biotechs with odds this good. And every penny biotech gets manipulated once in awhile and spikes -- if that happens before the real news arrives, I'll take some profits and laugh all the way to the bank.

Of course it's still a gamble. It's a penny biotech. You don't have the stomach for it, fine, stay on the sidelines and shake your fists and curse the darkness. But don't fool yourself into thinking anyone is listening to you or cares what you say. Sorry, but you lost all credibility when you claimed the CEO stole all the money, they'd never start US clinicals, and the Directors didn't even exist -- and even worse, you used multiple aliases to simulate a fake conversation.

Out of 151K stock traded today, only 6.5K was buys whereas almost 144K sells. You can easily judge how much huge bearish sentiment out there.

Now is when you should log on with your other alias and agree with yourself to create the false appearance of a conversation.

I also added today.

$ averaging on a penny stock. The worst strategy of all time. The chances that this stock will go above 0.15$ and continue to stay above 0.15$ are slim-to-none. Each & every bid above 0.123$ is taken immediately. The moment it will try to go above 0.15$, it will be brought back down by heavy selling. Looking at today’s trading there doesn’t appear to be any hope for the stock.

Oh, really? Have you looked at stock price lately?!
It’s sell, sell & nothing but sell. Stockholders are having so much bearish sentiments that they are even selling at 0.123$. There are 10K stocks available at 0.15$ but neither buyers nor any buying interest.

Adding more I hope I am doing the right thing trying to average down$$$

Getting very close should be above 10$ soon

press release today: China update.

https://www.businesswire.com/news/home/20240220053013/en/Leading-Cervical-Cancer-Doctors-Support-Approval-of-LuViva-in-China-Based-on-Preliminary-Review-of-Clinical-Trial-Results

I don't believe that SMI will pay Guided $4 million in 2024, but ANY money from SMI is a huge plus, and Guided can include the Chinese clinical data when they submit the updated PMA application.

The issue is that even if there are 5K stock available at bargain basement ask price of 0.15$, there are absolutely no buyers.
The issue is sellers are selling at any salvage price they can get. 0.14$ or 0.1382$ or even selling at 0.1250$. Yesterday someone put a bid for 0.1425$100K shares & that bid was so fast taken that even an eyeblink appeared slow. So from market perspective even a salvage price of 0.1425$ is overvalued.
The issue is lots of bullish sentiment/people on this forum but no one is willing to buy this stock. It’s just empty words. Unless bullish sentiment is actioned by buy orders, they are just empty words. Where are buys? Anyone?!

Just another lie. You'll never go away. More likely, you'll create a THIRD alias and have a FUD circle-jerk.

If you had something of substance to say here, fine, we could debate, but you don't. You just complain because a penny stock with no news doesn't skyrocket.

Let's get this straight -- you claim that "real buyers" could drive this stock from 15 cents to $5 with no news. 15 cents to $5. Over 3000% increase. On no news.

You've seen this happen before in the stock market, EVER? Name the ticker. Remember: there can't have been any news.

I've seen the occasional rare 3000% increase, but only on pennystocks that were beaten down and got unexpected news. With GTHP the news is expected and it's not beaten down at 15 cents - -that's the resulting price from the last R/S.

You lost money on GTHP after that last FDA rejection and resulting death spiral R/S, and it made you feel bad about yourself. You're holding a grudge and it makes you feel a little bit better about yourself to try and make others feel bad today. Well, news flash, I lost money on that last FDA rejection, but I didn't feel bad about myself then and I don't feel bad now. That's the pennystock biotech game we're playing: high risk, high rewards.

I sold right after the FDA rejection because that's how to play this game -- take your loss and move on. I stayed away when they sank into death spiral financing, but somehow Cartwright chased the toxic lender moneychangers out of the temple and pulled the company out of the death spiral. Now THERE's a thing I've never seen before. So I'm back in, and I expect to make money on this stock, although $5 per share is ludicrous even with PMA approval.

You couldn't handle the risk -- no shame in that. Not everyone can handle the risks of gambling on penny biotech. You should buy ETF's instead. And if you stop your mindless childish bashing of GTHP, you might actually get over your losses and start feeling better about yourself.

BTW, Auctus filed their annual Valentines' Day 13G. They hold more today than they held last year, even after they dumped their ill-gotten shares last June.

I’ll go away when people like YOU start buying at ask price. When are YOU buying at ask price?
It’s time to put-up or shut-up. It’s time to put your money where your mouth is. Show your buys at ask price.
My challenge to everyone is still open. Get this stock price to a respectable level of 1$ or 3$ or 5$ or higher & then I’ll not only be impressed but I’ll go away as well.

How about YOU...sell, sell and sell some more, then go away so that we can get some intelligent minds on this forum. you provide...at best, elementary knowledge of the capital markets and its not impressing anyone.

Really? Did you check how many shorts are there?
It’s sell-sell-&-more sell. Sell at any bid price you can get. Sell at any salvage bargain basement price you can get.